Filing Flows › Abbott Laboratories (ABT) › Q4 2025
Abbott Laboratories (ABT) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Feb 20, 2026
Abbott Laboratories (ABT) reported revenue of $11.5B for the fourth quarter 2025 (Q4 2025), +4% from a year earlier and +0.8% from the quarter before. Operating margin was 19.6%, net earnings $1.8B (15.5% of revenue).
Abbott Laboratories, Q4 2025: revenue $11.5B (+4% year over year), operating margin 19.6%, net earnings $1.8B, operating cash flow $3.3B. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $11.5B | +0.8% | +4% |
| Operating profit | $2.3B | +9% | +18% |
| Net earnings | $1.8B | +8% | -81% |
| Operating cash flow | $3.3B | +19% | +16% |
| Free cash flow | $2.6B | +15% | +22% |
What changed
Revenue was $11.5B in Q4 2025, up 4% year over year and up 1% from the previous quarter.
Operating profit was $2.3B, a 19.6% margin (up 2.2 points year over year). Of the extra revenue versus a year earlier, 70% reached operating profit, above the 17% margin then. Total costs grew 2% against revenue growth of 4%. Net earnings were $1.8B, down 81% year over year. The effective tax rate was 24.7%.
Operating cash flow was $3.3B (up 16% year over year), 187% of net earnings. Non-cash charges added back $0.79B of depreciation and amortization and $0.11B of share-based compensation. Working capital and other items added $0.63B. Capital expenditures of $0.69B left free cash flow of $2.6B.
Questions
What was Abbott Laboratories' revenue in the fourth quarter 2025?
Abbott Laboratories (ABT) reported revenue of $11.5B for the fourth quarter 2025 (Q4 2025), +4% from a year earlier and +0.8% from the quarter before.
Was Abbott Laboratories profitable in the fourth quarter 2025?
Operating profit was $2.3B (19.6% of revenue) and net earnings $1.8B.